For assessing myocardial injury following percutaneous coronary intervention (PCI), troponin I is overly sensitive and fails to distinguish procedure-related myocardial infarction (MI) from minor ...
New Haven, CT - The use of guideline-based therapies remains underused in older AMI patients admitted to the hospital and testing positive for troponin, a new study has shown [1]. Compared with ...
The widely used biomarker contributes to the hundreds of millions of dollars spent annually on cardiac care, but adds no value in evaluating patients with suspected acute coronary syndrome, ...
A new study is raising questions about how to best diagnose periprocedural myocardial infarction (MI) after elective stent placement. To detect event frequencies and predict 1-year mortality risk at ...
The diagnosis of acute myocardial infarction (MI) has always required -- in addition to history of chest pain and abnormal ECG changes -- laboratory evidence of myocardial damage. The traditional ...
Cardiac troponin I and T assays are indeed highly sensitive for the detection of myocardial injury. Approximately 30% of patients previously diagnosed with unstable angina with no increase in creatine ...
Patients who test positive for the presence of a specific biochemical marker of heart cell death in their blood but who do not exhibit other risk factors for future heart attack should be treated as ...
Researchers at the Johns Hopkins University School of Medicine and the Mayo Clinic have compiled peer-reviewed evidence and crafted a guideline designed to help physicians and medical centers stop the ...
Elevated levels of cardiac biomarkers following CABG surgery associated with increased risk of death
Patients who underwent coronary artery bypass graft surgery and had elevated levels of the cardiac enzymes creatine kinase or troponin in the 24 hours following surgery had an associated intermediate ...
Acute myocardial infarction (AMI) is a life-threatening event. Even with timely treatment, acute ischemic myocardial injury and ensuing ischemia reperfusion injury (IRI) can still be difficult issues ...
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results